The coronavirus vaccine reduced the risk of major cardiovascular events linked to covid-19 - strokes, heart attacks, and hospitalization from heart disease - by about 40 percent, according to a new ...

A vial of the Phase 3 Novavax coronavirus vaccine is seen ready for use in the trial at St. George's University hospital in London, on Oct. 7, 2020. (Alastair Grant/AP) (CN) — Billions of euros, ...

Shares of Novavax (NVAX) rose 0.58% to close at $8.67 on Tuesday, ending a six-session slide. The stock has fallen around 18% between June 1 and June 8, compared to a 2.56% decline in the S&P 500 over ...

Share on Pinterest What does the ‘world-first’ vaccine designed by artificial intelligence mean for public health? Image credit: Luis Velasco/Getty Images Researchers at the University of Cambridge ...

Novavax (NVAX) stock is in focus as Shah Capital again slams the company's leadership despite shareholder backing at the AGM. Read more here.

The COVID-19 vaccine lowered the risk of cardiovascular issues associated with the virus by around 40 percent, according to new research. The study, which was published in JAMA Internal Medicine on ...

Although most Americans have eschewed seasonal COVID-19 vaccines, the updated shots continue to show significant protection against cardiovascular disease, especially for those over age 75 and those ...

Moderna (MRNA) has surged 94% in 2026 so far, crushing Pfizer (PFE) at just +4% and beating Novavax (NVAX) at +41%, as Moderna's leadership restructuring has signaled a 2027-2028 product launch push.

You can listen to more articles from The Conversation, narrated by Noa, here. Researchers at the University of Cambridge have developed what they describe as a fundamentally new type of vaccine using ...

Novartis AG is to pay $1.1 billion up front to acquire Myricx Bio Ltd., a preclinical-stage antibody-drug conjugate (ADC) specialist that is advancing a novel and more potent class of payload. With ...

RNA vaccines represent a transformative advance in vaccinology, combining rapid development timelines, scalable manufacturing ...